Pulmonary Hypertension-COPD May Have Poorer Prognosis vs Idiopathic PAH
Patients with pulmonary hypertension and COPD appear to have a poorer prognosis than those with idiopathic pulmonary arterial hypertension.
News
LATEST NEWS
Community-Acquired Pneumonia: Many Antipseudomonal Drugs May Be Unnecessary
Many of the prescribed antipseudomonal drugs for patients with community-acquired pneumonia are potentially unnecessary.
Outcome Disparities in Pediatric Sepsis By Ethnicity, Insurance Status
Study authors sought to determine whether hospital outcomes in childhood severe sepsis were influenced by race, ethnicity, or insurance status, which are proxies for socioeconomic positions.
NIH: COVID-19 Convalescent Plasma Unlikely to Benefit Patients With Mild Symptoms
The trial enrolled 511 adult participants across 47 hospital emergency departments in the United States who had at least 1 risk factor for severe COVID-19.
Trilaciclib Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in Extensive-Stage SCLC
The approval was based on data from 3 randomized, placebo-controlled trials that included 245 adults with ES-SCLC.
People Living With HIV May Have Worse COVID-19 Outcomes
The acceleration of the COVID-19 pandemic continues to stress health care systems and exacerbate disparities in many communities, highlighting the importance of identifying patients at elevated risk of severe disease for COVID-19 vaccine prioritization.
Janssen’s Single-Shot COVID-19 Vaccine Receives Emergency Use Authorization
The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.
Gefapixant Under Review for Refractory Chronic Cough
The NDA submission is based on data from the double-blind, placebo-controlled phase 3 studies, COUGH-1 and COUGH-2.
UPCOMING MEETINGS
NOVEMBER 7
Annual New York Lung Cancer Symposium
Virtual | New York, NY
NOVEMBER 13-15
American College of Allergy, Asthma & Immunology (ACAAI) 2020 Annual Scientific Meeting
Virtual | Phoenix, AZ
DRUG NEWS FROM MPR
Cemiplimab Granted Priority Review for Advanced NSCLC
COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study
AstraZeneca Pauses COVID-19 Vaccine Trials
Additional Presentations of Ready-to-Use Premixed Vancomycin Bags Approved
Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD
Immune Responses Observed in All Participants Dosed With COVID-19 Vaccine Candidate
Combined Long-Acting Bronchodilator Therapy Compared With Monotherapy for COPD
Brigatinib Approved as First-Line Treatment for ALK-Positive Metastatic NSCLC
Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19
FDA: Scammers Continue to Sell Unproven Products for COVID-19
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
FDA Approves Imfinzi for Extensive-Stage Small Cell Lung Cancer
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
Pirfenidone Gets Breakthrough Therapy Status for Unclassifiable Interstitial Lung Disease
FDA: Cases of Respiratory Depression With Gabapentinoids Reported
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lung Infection
